Related content

Association of the exon 3 deleted/full-length GHR polymorphism with recombinant growth hormone dose in growth hormone-deficient adults

By Meyer Silke   Schaefer Stephan   Stolk Lisette   Arp Pascal   Uitterlinden Andréé G   Plööckinger Ursula   Stalla Güünter K   Tuschy Ulrich   Weber Matthias M   Weise Alexander   Pfüützner Andreas   Kann Peter H  

Pharmacogenomics, Vol. 10, Iss. 10, 2009-10 ,pp. : 1599-1608

Future Medicine

Access to resources Recommend Favorite

Effects of growth hormone deficiency and rhGH replacement therapy on the 6β-hydroxycortisol/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children

By Sinués Blanca   Mayayo Esteban   Fanlo Ana   JR Esteban   Bernal María   Bocos Pilar   Bello Elena   Labarta Jose   Ferrández-Longás Angel  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 8, 2004-10 ,pp. : 559-564

Springer Publishing Company

Access to resources Recommend Favorite

The Burden of Illness of Hypopituitary Adults with Growth Hormone Deficiency

By Hakkaart-van Roijen L.  

PharmacoEconomics, Vol. 14, Iss. 4, 1998-10 ,pp. : 395-403

Adis International

Access to resources Recommend Favorite

Clinical applications of recombinant human growth hormone in adults

By Iglesias P.   Díez J.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 1, 1999-11 ,pp. : 97-107

Informa Healthcare

Access to resources Recommend Favorite

Safety and efficacy of growth hormone replacement therapy in adults

By Toogood Andy  

Expert Opinion on Drug Safety, Vol. 4, Iss. 6, 2005-11 ,pp. : 1069-1082

Informa Healthcare

Access to resources Recommend Favorite